Journal
Annals of Clinical and Translational Neurology
Publication Date
1-1-2021
Volume
8
Issue
1
First Page
111
Last Page
118
Document Type
Open Access Publication
DOI
10.1002/acn3.51251
Rights and Permissions
Goodman, A.D., Fedler, J.K., Yankey, J., Klingner, E.A., Ecklund, D.J., Goebel, C.V., Bermel, R.A., Chase, M., Coffey, C.S., Klawiter, E.C., Naismith, R.T., Fox, R.J. and (2021), Response to ibudilast treatment according to progressive multiple sclerosis disease phenotype. Ann. Clin. Transl. Neurol., 8: 111-118. https://doi.org/10.1002/acn3.51251 © 2021 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Recommended Citation
Goodman, Andrew D; Fedler, Janel K; Yankey, Jon; Klingner, Elizabeth A; Ecklund, Dixie J; Goebel, Christopher V; Bermel, Robert A; Chase, Marianne; Coffey, Christopher S; Klawiter, Eric C; Naismith, Robert T; Fox, Robert J; and SPRINT-MS Investigators, "Response to ibudilast treatment according to progressive multiple sclerosis disease phenotype." Annals of Clinical and Translational Neurology. 8, 1. 111 - 118. (2021).
https://digitalcommons.wustl.edu/open_access_pubs/11233
Appendix S1. NN102/ SPRINT-MS Clinical Site Personnel, Investigator listing as of July 2016.
